- Home
- DSGX vs ZLAB Comparison
DSGX vs ZLAB Comparison
Compare DSGX & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGX
- ZLAB
- Stock Information
- Founded
- DSGX 1981
- ZLAB 2013
- Country
- DSGX Canada
- ZLAB China
- Employees
- DSGX N/A
- ZLAB N/A
- Industry
- DSGX Computer Software: Prepackaged Software
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- DSGX Technology
- ZLAB Health Care
- Exchange
- DSGX Nasdaq
- ZLAB Nasdaq
- Market Cap
- DSGX 8.8B
- ZLAB 3.6B
- IPO Year
- DSGX 1999
- ZLAB 2017
- Fundamental
- Price
- DSGX $103.85
- ZLAB $36.40
- Analyst Decision
- DSGX Buy
- ZLAB Buy
- Analyst Count
- DSGX 7
- ZLAB 5
- Target Price
- DSGX $125.14
- ZLAB $54.28
- AVG Volume (30 Days)
- DSGX 512.5K
- ZLAB 886.5K
- Earning Date
- DSGX 06-04-2025
- ZLAB 08-05-2025
- Dividend Yield
- DSGX N/A
- ZLAB N/A
- EPS Growth
- DSGX 17.84
- ZLAB N/A
- EPS
- DSGX 1.65
- ZLAB N/A
- Revenue
- DSGX $668,391,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- DSGX $11.87
- ZLAB $44.07
- Revenue Next Year
- DSGX $13.36
- ZLAB $49.13
- P/E Ratio
- DSGX $61.12
- ZLAB N/A
- Revenue Growth
- DSGX 13.74
- ZLAB 43.72
- 52 Week Low
- DSGX $90.61
- ZLAB $16.01
- 52 Week High
- DSGX $124.31
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- DSGX 52.11
- ZLAB 52.67
- Support Level
- DSGX $100.08
- ZLAB $34.79
- Resistance Level
- DSGX $103.76
- ZLAB $36.73
- Average True Range (ATR)
- DSGX 2.25
- ZLAB 1.23
- MACD
- DSGX 0.57
- ZLAB -0.46
- Stochastic Oscillator
- DSGX 97.12
- ZLAB 25.91
About DSGX Descartes Systems Group Inc. (The)
Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.